{
   "archive_url" : "http://www.ebi.ac.uk/ena/data/view/ERX297434",
   "experiment" : {
      "EXPERIMENT_TYPE" : "Histone H3K9me3",
      "EXPERIMENT_ID" : "ERX297434",
      "attributes" : {
         "EXTRACTION_PROTOCOL_SONICATION_CYCLES" : [
            "3x 10 min; 30 sec ON/ 30 sec OFF"
         ],
         "CHIP_ANTIBODY" : [
            "H3K9me3"
         ],
         "CHIP_PROTOCOL_BEAD_TYPE" : [
            "magnetic beads A and G"
         ],
         "CHIP_ANTIBODY_CATALOG" : [
            "pAb-056-050"
         ],
         "CHIP_PROTOCOL_BEAD_AMOUNT" : [
            "20 µl"
         ],
         "EXPERIMENT_TYPE" : [
            "Histone H3K9me3"
         ],
         "CHIP_PROTOCOL_ANTIBODY_AMOUNT" : [
            "2,0 µg"
         ],
         "CHIP_ANTIBODY_LOT" : [
            "A1671-001P"
         ],
         "CHIP_PROTOCOL_CHROMATIN_AMOUNT" : [
            "5x 100.000 cells = 5x 6,7 µl"
         ],
         "EXTRACTION_PROTOCOL" : [
            "Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."
         ],
         "CHIP_PROTOCOL" : [
            "Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin with antibody and A/G magnetic beads. Wash twice with buffer 1, once with buffer 2 and 3 and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."
         ],
         "CHIP_ANTIBODY_PROVIDER" : [
            "Diagenode"
         ],
         "EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR" : [
            "Bioruptor Plus (UCD-300)"
         ]
      },
      "ASSAY_TYPE" : "ChIP-Seq"
   },
   "archive" : "ENA",
   "ftp_path" : "http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS",
   "files" : [
      {
         "FORMAT" : "bigWig",
         "SIZE" : "1.4G",
         "NAME" : "BP_BL-2_c01.H3K9me3.wiggler.20130819.bw",
         "FILE_TYPE" : "CS_WIGGLER",
         "ANALYSIS_GROUP" : "EMBL-EBI",
         "TYPE" : "Normalized signal",
         "PATH" : "http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BP_BL-2_c01.H3K9me3.wiggler.20130819.bw",
         "PROTOCOL_DOC" : "chip_seq",
         "MD5" : "eddd2ffcca88c18e42bdebeb9a18694d"
      },
      {
         "FORMAT" : "bigBed",
         "SIZE" : "575K",
         "NAME" : "BP_BL-2_c01.H3K9me3.ppqt_macs2_broad_v2.20130819.bb",
         "FILE_TYPE" : "CS_MACS_TRACK_BROAD_BB",
         "ANALYSIS_GROUP" : "EMBL-EBI",
         "TYPE" : "Enriched regions",
         "PATH" : "http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BP_BL-2_c01.H3K9me3.ppqt_macs2_broad_v2.20130819.bb",
         "PROTOCOL_DOC" : "chip_seq",
         "MD5" : "b89cf85233692f75b04e018d1fc1cc36"
      },
      {
         "FORMAT" : "BED",
         "SIZE" : "723K",
         "NAME" : "BP_BL-2_c01.H3K9me3.ppqt_macs2_broad_v2.20130819.bed.gz",
         "FILE_TYPE" : "CS_BROAD_MACS2",
         "ANALYSIS_GROUP" : "EMBL-EBI",
         "TYPE" : "Enriched regions",
         "PATH" : "http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BP_BL-2_c01.H3K9me3.ppqt_macs2_broad_v2.20130819.bed.gz",
         "PROTOCOL_DOC" : "chip_seq",
         "MD5" : "0362279715484cc88823d9ec5d297e2f"
      },
      {
         "FORMAT" : "Text",
         "SIZE" : "826K",
         "NAME" : "BP_BL-2_c01.H3K9me3.ppqt_macs2_broad_v2.20130819.xls.gz",
         "FILE_TYPE" : "CS_BROAD_MACS2",
         "ANALYSIS_GROUP" : "EMBL-EBI",
         "TYPE" : "Enriched regions",
         "PATH" : "http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BP_BL-2_c01.H3K9me3.ppqt_macs2_broad_v2.20130819.xls.gz",
         "PROTOCOL_DOC" : "chip_seq",
         "MD5" : "6b855a70a47510792f079c8085ac2d54"
      }
   ],
   "sample" : {
      "SAMPLE_DESC_2" : "BL-2",
      "SAMPLE_DESC_1" : "Cell Line",
      "sample_name" : "BL-2_c01",
      "SAMPLE_DESC_3" : "Sporadic Burkitt lymphoma",
      "attributes" : {
         "DIFFERENTIATION_METHOD" : [
            "Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"
         ],
         "MOLECULE" : [
            "genomic DNA"
         ],
         "DISEASE" : [
            "Sporadic Burkitt lymphoma"
         ],
         "BIOMATERIAL_PROVIDER" : [
            "DSMZ"
         ],
         "BATCH" : [
            "NA"
         ],
         "LINEAGE" : [
            "NA"
         ],
         "BIOMATERIAL_TYPE" : [
            "Cell Line"
         ],
         "DISEASE_ONTOLOGY_URI" : [
            {
               "url" : "http://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=C1336077",
               "label" : "C1336077"
            }
         ],
         "SAMPLE_ONTOLOGY_URI" : [
            {
               "url" : "http://www.ebi.ac.uk/efo/EFO_0001639",
               "label" : "EFO_0001639"
            }
         ],
         "PASSAGE" : [
            "NA"
         ],
         "SEX" : [
            "Male"
         ],
         "DIFFERENTIATION_STAGE" : [
            "B cell"
         ],
         "MEDIUM" : [
            "RPMI 1640 + 10%FBS + 1% Glutamine"
         ],
         "LINE" : [
            "BL-2"
         ]
      }
   }
}
